关注
Jianying XU
Jianying XU
在 campus.lmu.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Current status and advances of immunotherapy in nasopharyngeal carcinoma
JY Xu, XL Wei, YQ Wang, FH Wang
Therapeutic Advances in Medical Oncology 14, 17588359221096214, 2022
452022
Association of plasma Epstein-Barr virus DNA with outcomes for patients with recurrent or metastatic nasopharyngeal carcinoma receiving anti–programmed cell death 1 immunotherapy
JY Xu, XL Wei, C Ren, Y Zhang, YF Hu, JY Li, JL Chen, YQ Wang, F Han, ...
JAMA Network Open 5 (3), e220587-e220587, 2022
292022
The impact of mismatch repair status on prognosis of patients with gastric cancer: a multicenter analysis
WL Guan, Y Ma, YH Cui, TS Liu, YQ Zhang, ZW Zhou, JY Xu, LQ Yang, ...
Frontiers in Oncology 11, 712760, 2021
242021
Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer
XL Wei, JY Xu, DS Wang, DL Chen, C Ren, JN Li, F Wang, FH Wang, ...
Therapeutic advances in medical oncology 13, 1758835921988996, 2021
222021
Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature
JY Xu, WL Guan, SX Lu, XL Wei, WJ Shi, C Ren, YH Li, SP Li, MZ Qiu, ...
Clinical Medicine Insights: Oncology 16, 11795549221090186, 2022
132022
ClC‐3 chloride channels are involved in estradiol regulation of bone formation by MC3T3‐E1 osteoblasts
Z Deng, W Li, J Xu, M Yu, D Li, Q Tan, D Wang, L Chen, L Wang
Journal of Cellular Biochemistry 120 (5), 8366-8375, 2019
102019
Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians
J Wang, J Zhuge, D Feng, B Zhang, J Xu, D Zhao, Z Fei, X Huang, W Shi
BMC cancer 22 (1), 273, 2022
62022
系统目前无法执行此操作,请稍后再试。
文章 1–7